Jeremy Nighohossian, Senior Fellow and Economist at the Competitive Enterprise Institute, discusses positive developments in healthcare, including changes in drug development, what the resignation of FDA Commissioner Marty Makary may mean for healthcare policy, and why Certificate of Need (CON) laws impede free market competition and access to care.